Home › Kanser sa Prostate › Delaware › Newark
Pag-aaral pangklinika para sa Kanser sa Prostate sa Newark, DE
Isang pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Newark. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Nagre-recruitPhase 2
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Nagre-recruitPhase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Nagre-recruitPhase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Nagre-recruitPhase 3
- Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- Helen F Graham Cancer Center, Newark
- Christiana Care Health System-Christiana Hospital, Newark
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Nagre-recruitPhase 1/2
- Medical Oncology Hematology Consultants, Newark
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Nagre-recruitPhase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- Christiana Care Health System-Christiana Hospital, Newark
- at 1 pa
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Nagre-recruitPhase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- Christiana Care Health System-Christiana Hospital, Newark
- at 1 pa
Vitamin D for Prostate Endocrine Therapy
Nagre-recruitPhase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Newark
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY101 pag-aaral
- Houston, TX73 pag-aaral
- Los Angeles, CA64 pag-aaral
- Boston, MA56 pag-aaral
- Seattle, WA45 pag-aaral
- St. Louis, MO45 pag-aaral
- Chicago, IL45 pag-aaral
- Baltimore, MD45 pag-aaral
- San Francisco, CA44 pag-aaral
- Philadelphia, PA41 pag-aaral
- Nashville, TN40 pag-aaral
- Washington, DC39 pag-aaral
Iba pang pag-aaral sa Newark
- Non-Small Cell Lung Cancer15 pag-aaral
- Colorectal Cancer9 pag-aaral
- Kanser sa Baga9 pag-aaral
- Metastatic Cancer8 pag-aaral
- Kanser sa Suso8 pag-aaral
- Kanser sa Pancreas6 pag-aaral
- Kanser (lahat ng uri)6 pag-aaral
- Kanser sa Ovary5 pag-aaral
- Kanser sa Pantog4 pag-aaral
- Chronic Lymphocytic Leukemia4 pag-aaral
- Kanser sa Tiyan4 pag-aaral
- Melanoma4 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.